Intercept Pharmaceuticals, Inc. (ICPT)

Today's Latest Price: $35.40 USD

0.20 (0.57%)

Updated Dec 4 4:00pm

Add ICPT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

Intercept Pharmaceuticals Inc (ICPT) Price Targets From Analysts

Use the tables below to see what analysts covering Intercept Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
23 $116 $33 $56.39 $35.2 60.2%

ICPT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.7 6 2 15 0 0 23

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ICPT as an investment opportunity.

  • ICPT has a lower percent of analysts bearish on the stock than nearly 100% of all US stocks.
  • ICPT has a greater number of analysts covering the stock than 99.6% of stocks in the mid market cap category.
  • The variance in analysts' estimates of ICPT is less than 1.2% of stocks in the mid market cap category.
  • Intercept Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 92.15% of stocks in the mid market cap category.
  • ICPT has a higher percentage of analysts bullish on the stock than 11% of Healthcare stocks.
  • The average analyst price target of ICPT is greater than 82.04% of Pharmaceutical Products stocks.
  • ICPT has a less change in bullishness amongst analysts than nearly 100% of all US stocks.

Stocks similar to Intercept Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BMRN, TEVA and PFE.

Is ICPT a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6261 seconds.